Sunovion Extension-A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects with Schizophrenia and Subjects with Irritability Associated with Autistic Disord